Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDSB | AMGN | BMY | GILD | VRTX |
| Company | Pds Biotechnology Corp | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 3.85 | 313.39 | 43.90 | 65.51 | 401.50 |
| High | 3.96 | 322.60 | 44.33 | 65.53 | 405.67 |
| Low | 3.74 | 308.68 | 43.69 | 64.33 | 397.59 |
| Last | 3.82 | 311.29 | 43.99 | 64.78 | 401.08 |
| Change | +0.09 | +32.90 | +0.29 | -0.55 | +0.92 |
| % Change | +2.41% | +11.82% | +0.66% | -0.84% | +0.23% |
| Volume | 430,900 | 9,644,601 | 12,104,400 | 7,822,700 | 1,064,000 |
| 20-Day Average Volume | 652,655 | 2,646,885 | 14,464,405 | 7,406,455 | 1,022,600 |
| Previous Close | 3.73 | 278.39 | 43.70 | 65.33 | 400.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.20 | 272.27 | 47.46 | 66.88 | 398.43 |
| 20-Day Raw Stochastic | 89.78% | 81.73% | 7.87% | 8.01% | 63.17% |
| 20-Day Relative Strength | 50.68% | 72.10% | 29.25% | 30.11% | 47.14% |
| Weighted Alpha | -39.04 | +33.76 | -36.67 | -22.64 | +14.36 |
| Today's Opinion | 88% Sell | 24% Buy | 100% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Sell | 16% Sell | 88% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 72% Sell | 24% Sell | 8% Sell | 100% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.82% since 04/26/24 | +15.30% since 04/26/24 | -1.92% since 04/26/24 | -0.98% since 04/26/24 | +0.91% since 04/26/24 |
| Low | 3.25 on 04/29/24 | 268.99 on 04/29/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.70 on 04/30/24 |
| High | 3.96 on 05/03/24 | 322.60 on 05/03/24 | 45.38 on 04/29/24 | 66.91 on 04/29/24 | 406.95 on 05/01/24 |
| 1-Month | |||||
| %Chg | +3.80% since 04/03/24 | +13.44% since 04/03/24 | -15.70% since 04/03/24 | -8.62% since 04/03/24 | -1.89% since 04/03/24 |
| Low | 2.59 on 04/19/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 3.96 on 05/03/24 | 322.60 on 05/03/24 | 52.08 on 04/04/24 | 71.39 on 04/04/24 | 412.64 on 04/04/24 |
| 3-Month | |||||
| %Chg | -29.39% since 02/02/24 | -3.68% since 02/02/24 | -9.69% since 02/02/24 | -15.83% since 02/02/24 | -5.56% since 02/02/24 |
| Low | 2.59 on 04/19/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 |
| High | 6.68 on 03/04/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 77.87 on 02/06/24 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | -16.04% since 11/03/23 | +15.35% since 11/03/23 | -16.72% since 11/03/23 | -20.60% since 11/03/23 | +6.61% since 11/03/23 |
| Low | 2.59 on 04/19/24 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 341.90 on 11/16/23 |
| High | 6.85 on 11/16/23 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 136,813 | 149,321,728 | 88,584,272 | 81,340,888 | 103,424,960 |
| Shares Outstanding, K | 36,679 | 536,376 | 2,027,100 | 1,245,077 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -42,940,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,865,000,000 | 6,686,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -10,900,000 | 767,000,000 | -11,911,000,000 | -4,170,000,000 | 968,800,000 |
| 60-Month Beta | 1.75 | 0.60 | 0.45 | 0.22 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 03/27/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 42.10 | 16.26 | 29.92 |